10x Genomics, Inc.
TXG- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001770787
In the last 90 days, 10x Genomics, Inc. insiders filed 0 open-market purchases and 11 sales; 393 institutions reported holding it in 13F filings for Q2 2026, worth $4.92B in total; superinvestors ARK Invest and Duquesne Family Office hold it.
13F holders, Q1 2025
Institutional positions in 10x Genomics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 274
- +3 vs. Q4 2024
- Shares held
- 114.1M
- +9.68M (+9.3%) vs. Q4 2024
- Total value
- $995.9M
- −$504.5M (−33.6%) vs. Q4 2024
- New holders
- 48
- 109 more added
- Sold out
- 45
- 74 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TXG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 393 | $4.92B |
| Q1 2026 | 332 | $2.66B |
| Q4 2025 | 323 | $2.01B |
| Q3 2025 | 317 | $1.44B |
| Q2 2025 | 297 | $1.42B |
| Q1 2025 | 274 | $995.9M |
| Q4 2024 | 273 | $1.50B |
| Q3 2024 | 266 | $2.36B |
| Q2 2024 | 261 | $2.05B |
| Q1 2024 | 290 | $3.89B |
| Q4 2023 | 275 | $5.37B |
| Q3 2023 | 257 | $3.75B |
| Q2 2023 | 274 | $4.98B |
| Q1 2023 | 259 | $5.03B |
| Q4 2022 | 268 | $3.19B |
| Q3 2022 | 234 | $2.45B |
| Q2 2022 | 254 | $3.91B |
| Q1 2022 | 313 | $6.30B |
| Q4 2021 | 365 | $11.9B |
| Q3 2021 | 332 | $11.5B |
| Q2 2021 | 342 | $15.3B |
| Q1 2021 | 324 | $12.8B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding 10x Genomics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −17,305−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −16,705−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| Teza Capital Management LLC | 0 | $0 | 0.00% | −16,096−100.0% | Sold out |
| Farringdon Capital, Ltd. | 0 | $0 | 0.00% | −14,767−100.0% | Sold out |
| Sands Capital Management, LLC | 0 | $0 | 0.00% | −12,542−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −11,136−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −10,137−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,224−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −3,578−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,426−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −1,124−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −489−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| Hemington Wealth Management | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Colonial Trust Co | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |